Organization | Chong Kun Dang Pharmaceutical

Chong Kun Dang Pharmaceutical Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4

Founded: Seoul Korea, Republic of (1941)

Status: No NME R&D (1941)

Organization Overview

First Clinical Trial

2007

NCT01030679

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Chong Kun Dang pharm | Chong Kun Dang Pharm. | Chong Kun Dang Pharmaceutical | Chong Kun Dang Pharmaceutical Company | Chong Kun Dang Pharmaceutical Corp. | CKD Pharmaceutical Limited | Seoul, Gwanak-gu, South Korea, 08779 | yangch@catholic.ac.kr

Active Ingredients

Drugs in Phase 4 Trials (31)

5,7-dihydroxy-3',4',6-trimethoxyflavone (1 trial)

acetylsalicylic acid (aspirin) (5 trials)

amlodipine (norvasc) (29 trials)

atorvastatin (lipitor) (23 trials)

basiliximab (Simulect) (1 trial)

betamethasone (celestone) (1 trial)

candesartan (atacand) (16 trials)

carvedilol (coreg) (7 trials)

celecoxib (celebrex) (1 trial)

clopidogrel (plavix) (5 trials)

entecavir (baraclude) (1 trial)

esomeprazole (nexium) (5 trials)

everolimus (zortress) (2 trials)

flecainide (tambocor) (1 trial)

imotun (2 trials)

l-alpha-glycerophosphocholine (2 trials)

lobeglitazone (32 trials)

losartan (cozaar) (1 trial)

methylprednisolone (medrol) (1 trial)

mycophenolate (CellCept) (9 trials)

naltrexone (revia) (1 trial)

olmesartan (benicar) (1 trial)

phenazopyridine (gantanol) (1 trial)

prednisone (meticorten) (1 trial)

quinapril (accupril) (4 trials)

rabeprazole (pariet) (1 trial)

sirolimus (rapamune) (2 trials)

sitagliptin (januvia) (7 trials)

tacrolimus (prograf) (9 trials)

telmisartan (micardis) (21 trials)

valsartan (diovan) (1 trial)

Drugs in Phase 3 Trials (32)

artemisia (2 trials)

bardoxolone (1 trial)

belotecan (4 trials)

budesonide (rhinocort) (2 trials)

cetirizine (zyrtec) (2 trials)

cisplatin (platinol) (1 trial)

ckd-386 (10 trials)

ckd-825 (1 trial)

d930 (4 trials)

dapagliflozin (farxiga) (5 trials)

darbepoetin alfa (aranesp) (4 trials)

dexamethasone (9 trials)

dexmedetomidine (precedex) (2 trials)

dimethyltryptamine (1 trial)

diquafosol (1 trial)

empagliflozin (jardiance) (5 trials)

etoposide (vepesid) (1 trial)

ezetimibe (zetia) (6 trials)

fenofibrate (fenoglide) (6 trials)

hyaluronic acid (1 trial)

hydrochlorothiazide (esidrix) (1 trial)

latanoprost (xalatan) (3 trials)

levamlodipine (Conjupri) (7 trials)

levocabastine (livostin) (1 trial)

mometasone (elocon) (1 trial)

nafamostat (ronastat) (3 trials)

pioglitazone (actos) (1 trial)

ranibizumab (lucentis) (1 trial)

tadalafil (cialis) (4 trials)

tamsulosin (flomax) (6 trials)

tenofovir (viread) (2 trials)

xenobella (1 trial)

Drugs in Phase 2 Trials (15)

avelumab (bavencio) (1 trial)

ckd-497 (1 trial)

ckd-506 (1 trial)

ckd-516 (3 trials)

ckd-519 (9 trials)

docetaxel (taxotere) (2 trials)

dorzolamide (trusopt) (1 trial)

erlotinib (tarceva) (1 trial)

gefitinib (iressa) (1 trial)

gemcitabine (gemzar) (2 trials)

mizoribine (1 trial)

oxaliplatin (eloxatin) (1 trial)

rebamipide (1 trial)

rosuvastatin (crestor) (3 trials)

topotecan (hycamtin) (2 trials)

Drugs in Phase 1 Trials (47)

ckd-320 (1 trial)

ckd-333 (6 trials)

ckd-341 (1 trial)

ckd-344 (2 trials)

ckd-348 (7 trials)

ckd-349 (4 trials)

ckd-371 (1 trial)

ckd-379 (1 trial)

ckd-380 (1 trial)

ckd-381 (4 trials)

ckd-382 (2 trials)

ckd-383 (1 trial)

ckd-385 (6 trials)

ckd-387 (4 trials)

ckd-388 (2 trials)

ckd-393 (4 trials)

ckd-504 (1 trial)

ckd-508 (1 trial)

ckd-510 (2 trials)

ckd-581 (3 trials)

ckd-702 (1 trial)

ckd-810 (1 trial)

d484 (2 trials)

d565 (2 trials)

donepezil (aricept) (2 trials)

fluconazole (diflucan) (6 trials)

imatinib (gleevec) (1 trial)

iron (2 trials)

ketoconazole (nizoral) (2 trials)

lenalidomide (revlimid) (1 trial)

leuprolide (lupron) (2 trials)

lixiana (2 trials)

memantine (namenda) (2 trials)

metformin (glucophage) (5 trials)

nov120401 (1 trial)

testosterone (delatestryl) (1 trial)

ticagrelor (brilinta) (1 trial)

tofacitinib (xeljanz) (2 trials)

voriconazole (vfend) (1 trial)

warfarin (coumadin) (1 trial)

Drugs in Other Trials (8)

autologous umbilical cord blood (1 trial)

bismuth (1 trial)

clarithromycin (biaxin) (1 trial)

epoetin (Epogen) (1 trial)

metronidazole (flagyl) (1 trial)

pantoprazole (protonix) (1 trial)

procaine benzylpenicillin (novocaine) (1 trial)

tetracycline (tetrex) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acute Coronary Syndrome (Phase 1)

Alzheimer Disease (Phase 1)

Anemia (Phase 3)

Angina, Stable (Phase 1)

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Aspergillosis (Phase 1)

Atrial Fibrillation (Phase 3)

Candidiasis (Phase 1)

Carcinoma (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 2)

Carcinoma, Small Cell (Phase 3)

Carcinoma, Transitional Cell (Phase 2)

Cardiovascular Diseases (Phase 4)

Central Nervous System Diseases (Phase 1)

Colorectal Neoplasms (Phase 2)

Communicable Diseases (Phase 1)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Dry Eye Syndromes (Phase 3)

Dyslipidemias (Phase 4)

Esophagitis (Phase 4)

Esophagitis, Peptic (Phase 4)

Essential Hypertension (Phase 3)

Eye Diseases (Phase 3)

Gastritis (Phase 4)

Gastroesophageal Reflux (Phase 4)

Gastrointestinal Stromal Tumors (Phase 1)

Glaucoma (Phase 3)

Glaucoma, Open-Angle (Phase 3)

Glomerulonephritis, IGA (Phase 4)

Heart Diseases (Phase 4)

Heart Failure (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis, Chronic (Phase 3)

Huntington Disease (Phase 1)

Hypercholesterolemia (Phase 4)

Hyperlipidemia, Familial Combined (Phase 3)

Hyperlipidemias (Phase 3)

Hyperplasia (Phase 3)

Hypertension (Phase 4)

Hypogonadism (Phase 1)

Infections (Phase 1)

Keratoconjunctivitis Sicca (Phase 3)

Kidney Diseases (Phase 4)

Leiomyosarcoma (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 1)

Liver Diseases (Phase 1)

Lung Neoplasms (Phase 3)

Lymphoma (Phase 1)

Multiple Myeloma (Phase 1)

Mycoses (Phase 1)

Myocardial Ischemia (Phase 4)

Neoplasms (Phase 1)

Neoplasms, Plasma Cell (Phase 1)

Nephrosis (Phase 4)

Nephrotic Syndrome (Phase 4)

Nervous System Diseases (Phase 1)

Ocular Hypertension (Phase 3)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Ovarian Neoplasms (Phase 2)

Pneumonia (Phase 2)

Premature Birth (Phase 4)

Prostatic Hyperplasia (Phase 3)

Recurrence (Phase 2)

Renal Insufficiency (Phase 1)

Renal Insufficiency, Chronic (Phase 3)

Respiratory Tract Infections (Phase 2)

Rhinitis (Phase 3)

Rhinitis, Allergic (Phase 3)

Rhinitis, Allergic, Perennial (Phase 3)

Small Cell Lung Carcinoma (Phase 3)

Syndrome (Phase 4)

Tachycardia (Phase 4)

Tachycardia, Ventricular (Phase 4)

Tricuspid Valve Insufficiency (Phase 3)

Ventricular Premature Complexes (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 253
# of Trial APIs: 133